RANK Ligand Inhibitor [EPC]

203750 reported adverse events

Drugs of this class: DENOSUMAB DENOSUMAB-BMWO DENOSUMAB-DESU DENOSUMAB-KYQQ DENOSUMAB-MOBZ DENOSUMAB-QBDE

These side effects are most commonly reported by patients taking drugs of the RANK Ligand Inhibitor [EPC] class:

# Side effect Count
0 OFF LABEL USE 36810
1 DEATH 20704
2 ARTHRALGIA 9015
3 OSTEONECROSIS OF JAW 8703
4 FATIGUE 7873
5 PAIN IN EXTREMITY 7089
6 PAIN 7048
7 BACK PAIN 7011
8 NAUSEA 5570
9 DIARRHOEA 5445
See all common reactions for RANK Ligand Inhibitor [EPC]

Drugs of the RANK Ligand Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE GIANT CELL TUMOUR 309 0.7984
1 EXOSTOSIS OF JAW 298 0.6008
2 OSTEONECROSIS OF EXTERNAL AUDITORY CANAL 103 0.5150
3 ATYPICAL FRACTURE 231 0.3750
4 OSTEONECROSIS OF JAW 8703 0.3513
5 ATYPICAL FEMUR FRACTURE 893 0.3162
6 TOOTH RESORPTION 65 0.3066
7 DENTAL CARE 567 0.3060
8 DENTAL IMPLANTATION 412 0.2517
9 OESTROGEN DEFICIENCY 69 0.2509
See all enriched reactions for RANK Ligand Inhibitor [EPC]